Scarica l'app Stockscreener
0.00
100.00%
-0.2071
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RNLX Giù?
Forum
Previsione
Precedente Chiudi:
$0.2071
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$17.18M
Reddito:
$2.41M
Utile/perdita netta:
$-42.50M
Rapporto P/E:
0.00
EPS:
-1.1
Flusso di cassa netto:
$-36.15M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$2.40
Renalytix Plc Adr Stock (RNLX) Company Profile
Nome
Renalytix Plc Adr
Settore
Industria
Telefono
44 29 2071 0570
Indirizzo
FINSGATE, LONDON
Renalytix Plc Adr Stock (RNLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-01-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-04 | Iniziato | BTIG Research | Buy |
| 2021-10-04 | Iniziato | Guggenheim | Buy |
| 2021-07-02 | Iniziato | Berenberg | Buy |
| 2020-08-11 | Iniziato | Stifel | Buy |
Renalytix Plc Adr Borsa (RNLX) Ultime notizie
Stock Market Recap: Renalytix Plc ADR (RNLX) Concludes at 0.21, a 5.66 Surge/Decline - The Dwinnex
What was Renalytix Plc ADR (RNLX)’s performance in the last session? - US Post News
Renalytix Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Ratios in Focus: Analyzing Renalytix Plc ADR (RNLX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Renalytix AI stock hits 52-week low at $0.22 amid market challenges - Investing.com
Renalytix Plc ADR (RNLX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
There is no way Renalytix Plc ADR (RNLX) can keep these numbers up - SETE News
How analysts predict Renalytix Plc ADR (RNLX) will perform this quarter? - US Post News
Renalytix Plc ADR (RNLX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Investor’s Delight: Renalytix Plc ADR (RNLX) Closes Strong at 0.31, Up 7.31 - The Dwinnex
Renalytix Plc ADR (RNLX) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Analyzing RNLX’s price-to-book ratio for the last quarter - US Post News
Renalytix Plc ADR (RNLX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Closing Figures: Renalytix Plc ADR (RNLX)’s Negative Finish at 0.31, Down -23.14 - The Dwinnex
Form 8.5 (EPT/RI)-Renalytix Plc - GlobeNewswire Inc.
Investing in Renalytix Plc ADR (RNLX) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Check out these key findings about Renalytix Plc ADR (RNLX) - SETE News
Renalytix Plc ADR Inc. (RNLX) Price Performance Over the Years: A Comparative Study - The InvestChronicle
What to expect from Renalytix Plc ADR’s (RNLX) current quarter earnings? - US Post News
Examining Renalytix Plc ADR (RNLX) more closely is necessary - US Post News
It is Poised to be a Bull Market for Renalytix Plc ADR (RNLX) - SETE News
Upward Trajectory: Renalytix Plc ADR (RNLX) Posts a Gaine, Closing at 0.34 - The Dwinnex
Is Renalytix Plc ADR (RNLX) a good investment opportunity? - US Post News
Renalytix Plc ADR Inc. (RNLX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Renalytix AI shares hold buy rating from HC Wainwright - Investing.com
- Invest Chronicle - The InvestChronicle
Barclays raises Alkami Technology target to $31 on growth outlook By Investing.com - Investing.com India
Renalytix Partners with Steno for Kidney Care in Europe - Investing.com
Did Renalytix Plc ADR (RNLX) perform well in the last session? – US Post News - US Post News
Market Watch Highlights: Renalytix Plc ADR (RNLX) Ends on an Upturn Note at 0.25 – DWinneX - The Dwinnex
Investing in Renalytix Plc ADR (RNLX) might be an excellent idea, but the stock is currently overvalued/undervalued ... - US Post News
Check out these key findings about Renalytix Plc ADR (RNLX) – Sete News - SETE News
Post-Trade Analysis: Renalytix Plc ADR (RNLX) Slides -28.97, Closing at 0.25 – DWinneX - The Dwinnex
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - Yahoo Finance UK
Renalytix Plc ADR (RNLX) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Renalytix Plc Share Chat (RENX) - London South East
Cummins raises dividend as streak continues By Investing.com - Investing.com
Renalytix faces delisting from Nasdaq over noncompliance - Investing.com India
Renalytix appoints CohnReznick as new auditor By Investing.com - Investing.com
Renalytix plc successful completion of $30.0 million financing package - The Globe and Mail
Is it possible to buy Renalytix Plc ADR(RNLX) shares at a good price now? – US Post News - US Post News
Renalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights - The Globe and Mail
Renalytix to Report Second Quarter and First Half Fiscal Year 2022 Financial Results on March 31 - The Globe and Mail
Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference - The Globe and Mail
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022 - The Globe and Mail
Renalytix to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - The Globe and Mail
Renalytix Appoints Ann Berman to its Board of Directors - The Globe and Mail
RNLX’s Market Whiplash: 40.54% YTD Rise, -3.33% Plunge in 30 Days - The InvestChronicle
Medicare sets $950 price for Renalytix kidney test By Investing.com - Investing.com
Renalytix Plc Share Chat. Chat About RENX SharesStock Quote, Charts, Trade History, Share Chat, Financial Terms ... - London South East
Medicare sets $950 price for Renalytix kidney test - Investing.com
Renalytix Plc Adr Azioni (RNLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.66%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):